SCHEMBL4396795

SCHEMBL4396795

CCC1CCC(OC(=O)C2CCCCC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ EPHX1 P07099 3/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ NAAA Q02083 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CHRM2 P08172 2/20 0.39
▸ CHRM4 P08173 2/20 0.39
▸ CHRM1 P11229 2/20 0.39
▸ CHRM3 P20309 2/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HTT P42858 2/20 0.37
▸ FABP7 O15540 1/20 0.36
▸ FABP5 Q01469 1/20 0.36
▸ CES2 O00748 1/20 0.35
▸ CES1 P23141 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18186693 0.86 ALDH1A1 (0.42) ALDH1A1EPHX1NAAASMN1; SMN2CHRM2
SCHEMBL11415801 0.86 CYP19A1 (0.43) ALDH1A1EPHX1CYP19A1NAAASMN1; SMN2
SCHEMBL16784670 0.84 CES2 (0.48) ALDH1A1EPHX1NAAASMN1; SMN2CHRM2
SCHEMBL17058997 0.84 CYP19A1 (0.42) ALDH1A1EPHX1CYP19A1SMN1; SMN2MEN1
SCHEMBL13401912 0.84 CYP19A1 (0.42) ALDH1A1EPHX1CYP19A1SMN1; SMN2MEN1
SCHEMBL18186694 0.83 CYP1A2 (0.52) ALDH1A1EPHX1NAAAHTT
SCHEMBL16203169 0.83 CYP19A1 (0.41) EPHX1CYP19A1SMN1; SMN2MEN1KMT2A
SCHEMBL22417521 0.81 SMN1; SMN2 (0.54) ALDH1A1EPHX1SMN1; SMN2CHRM2CHRM4
SCHEMBL24595803 0.80 EPHX1 (0.48) ALDH1A1EPHX1NAAASMN1; SMN2CHRM2
SCHEMBL5953668 0.80 EPHX1 (0.48) ALDH1A1EPHX1NAAASMN1; SMN2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10457628-B2 Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image FUJIFILM CORPORATION (JP) 2019-10-29 — — US disclosed
US-10323120-B2 Polymerizable composition containing polymerizable compound, film, and half mirror for displaying projection image FUJIFILM CORPORATION (JP) 2019-06-18 — — US disclosed
EP-3199561-B1 POLYMERIZABLE COMPOSITION COMPRISING POLYMERIZABLE COMPOUNDS, FILM, AND HALF MIRROR FOR PROJECTED-IMAGE DISPLAY FUJIFILM CORP (JP) 2019-01-09 — — EP disclosed
EP-3199561-A1 POLYMERIZABLE COMPOSITION COMPRISING POLYMERIZABLE COMPOUNDS, FILM, AND HALF MIRROR FOR PROJECTED-IMAGE DISPLAY Fujifilm Corporation (JP) 2017-08-02 — — EP disclosed
US-20170190821-A1 POLYMERIZABLE COMPOSITION CONTAINING POLYMERIZABLE COMPOUND, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE FUJIFILM CORPORATION (JP) 2017-07-06 — — US disclosed
US-20160318845-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE FUJIFILM CORPORATION (JP) 2016-11-03 — — US disclosed
US-8420764-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2013-04-16 — — US disclosed
US-20090306376-A1 OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME MITSUI CHEMICALS, INC. (JP) 2009-12-10 — — US disclosed
CN-101550076-A Manufacturing method of trans-isomer of 4-substituted-cyclohexane carboxylic acid FUJI PHOTO FILM CO LTD (JP) 2009-10-07 — — CN disclosed
US-7405030-B2 Imide compound and optical recording media made by using the same MITSUI CHEMICALS, INC. (JP) 2008-07-29 — — US disclosed
EP-1180765-B1 Optical recording medium and porphycene compound MITSUI CHEMICALS INC (JP) 2005-04-06 — — EP disclosed
EP-1484191-A1 REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE Sony Corporation (JP) 2004-12-08 — — EP disclosed
EP-1445115-A1 IMIDE COMPOUNDS AND OPTICAL RECORDING MEDIA MADE BY USING THE SAME Mitsui Chemicals, Inc. (JP) 2004-08-11 — — EP disclosed
US-20030194646-A1 Mono-, di-, and triazaporphyrin compounds optionally in the form of a metal or metalloid complex MITSUI CHEMICALS, INC. (JP) 2003-10-16 — — US disclosed
US-6627288-B1 Optical recording medium and porphycene compound MITSUI CHEMICALS, INC. (JP) 2003-09-30 — — US disclosed
US-20030091931-A1 Benzbisazole compound and optical recording medium containing the compound MITSUI CHEMICALS, INC. (JP) 2003-05-15 — — US disclosed
EP-1262966-A2 Optical recording medium and novel azaporphyrin compound Mitsui Chemicals, Inc. (JP) 2002-12-04 — — EP disclosed
EP-1247655-A1 OPTICAL RECORDING MEDIUM AND NOVEL AZAPORPHYRIN COMPOUNDS Mitsui Chemicals, Inc. (JP) 2002-10-09 — — EP disclosed
EP-1245571-A1 BENZBISAZOLE COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING THE COMPOUND Mitsui Chemicals, Inc. (JP) 2002-10-02 — — EP disclosed
EP-1180765-A1 Optical recording medium and porphycene compound Mitsui Chemicals, Inc. (JP) 2002-02-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10457628-B2 Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image PYM1, C5, C1S ALDH1A1 3142/4885EPHX1 3839/4885CYP19A1 3239/4885
US-20090306376-A1 OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME CACNA1B, KCNN4, KCNN2 ALDH1A1 4231/4885EPHX1 4030/4885CYP19A1 4587/4885
US-20030091931-A1 Benzbisazole compound and optical recording medium containing the compound DAO, CACNA1I, KCNB2 ALDH1A1 838/4885EPHX1 2040/4885CYP19A1 1835/4885
US-20160318845-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, FILM, AND HALF MIRROR FOR DISPLAYING PROJECTION IMAGE PYM1, C5, C1S ALDH1A1 3192/4885EPHX1 3903/4885CYP19A1 3362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback